Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Cerus (CERS) in Focus: Stock Moves 6% Higher in Session
Cerus Corporation (CERS - Free Report) was a big mover last session, as the company saw its shares rise a little over 6% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.19 to $6.97 in the past one-month time frame.
None of the estimates for this medical products industry stock were revised over the past 30 days. The Zacks Consensus Estimate however moved down over the same time frame, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if Friday’s move higher lasts.
Cerus has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.
CERUS CORP Price
CERUS CORP Price | CERUS CORP Quote
However, a better-ranked stock in the same space is LeMaitre Vascular, Inc. (LMAT - Free Report) , sporting a Zacks Rank #1 (Strong Buy).
Is CERS going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>